CXCL1 and breast carcinoma: Clinicopathological studies have suggested that CXCL1 exhibits elevated expression in breast cancer tissue than in normal tissue and is closely correlated with advanced tumour stage, increased recurrence and decreased overall survival in patients with breast cancer (Korbecki et al., 2023; Zou et al., 2014).